189747-31-7 Usage
Uses
Used in Pharmaceutical Development:
6-Chloropyrimido[5,4-d]pyrimidin-4(3H)-one is used as a key intermediate in the synthesis of pharmaceuticals for its potential to contribute to the development of new drugs with diverse therapeutic effects.
Used in Agrochemical Synthesis:
In the agrochemical industry, 6-Chloropyrimido[5,4-d]pyrimidin-4(3H)-one is utilized as a precursor in the creation of agrochemicals, helping to develop compounds that can protect crops and enhance agricultural productivity.
Used in Organic Synthesis:
6-Chloropyrimido[5,4-d]pyrimidin-4(3H)-one is employed as a versatile precursor in organic synthesis, allowing for the preparation of a wide range of chemical structures that can be applied in various scientific and industrial applications.
Used in Medicinal Research:
6-Chloropyrimido[5,4-d]pyrimidin-4(3H)-one is used as a research tool in medicinal chemistry to explore its potential in the treatment of various diseases, given its unique structural features and reactivity.
Used in Chemical Research:
6-Chloropyrimido[5,4-d]pyrimidin-4(3H)-one is utilized in chemical research to study its properties and reactions, contributing to the understanding of heterocyclic chemistry and its implications in material and life sciences.
Check Digit Verification of cas no
The CAS Registry Mumber 189747-31-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,9,7,4 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 189747-31:
(8*1)+(7*8)+(6*9)+(5*7)+(4*4)+(3*7)+(2*3)+(1*1)=197
197 % 10 = 7
So 189747-31-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H3ClN4O/c7-6-8-1-3-4(11-6)5(12)10-2-9-3/h1-2H,(H,9,10,12)
189747-31-7Relevant articles and documents
Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor
Rewcastle, Gordon W.,Bridges, Alexander J.,Fry, David W.,Rubin, J. Ronald,Denny, William A.
, p. 1820 - 1826 (1997)
A series of 6-substituted 4-anilinopyrimido[5,4-d]pyrimidines has been prepared and shown to be potent inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR). These compounds are structurally related to the pyrido[3,2-d]